betamethasone valerate has been researched along with Prurigo in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, H; Jeong, DH; Joo, C; Kang, HK; Kim, HK; Kim, JD; Lee, H; Lee, JH; Lee, JS; Lee, KH; Shin, JU; Song, S | 1 |
| Chimenti, S; Chiricozzi, A; Nisticò, SP; Saraceno, R; Tiberti, S | 1 |
| Enk, CD; Ingber, A; Levi, A | 1 |
| Akaraphanth, R; Gritiyarangsan, P | 1 |
4 other study(ies) available for betamethasone valerate and Prurigo
| Article | Year |
|---|---|
The use of biodegradable microneedle patches to increase penetration of topical steroid for prurigo nodularis.
Topics: Absorbable Implants; Adult; Anti-Inflammatory Agents; Betamethasone Valerate; Drug Implants; Female; Humans; Hyaluronic Acid; Male; Needles; Prurigo; Pruritus; Tomography, Optical Coherence | 2018 |
An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis.
Topics: Adult; Aged; Antipruritics; Betamethasone Valerate; Emollients; Female; Humans; Male; Middle Aged; Occlusive Dressings; Phytotherapy; Pilot Projects; Prurigo; Surgical Tape; Tanacetum parthenium; Treatment Outcome | 2010 |
Ultraviolet A1 exposure is crucial in the treatment of prurigo nodulalis using a ultraviolet A1/topical steroid combination regimen.
Topics: Adult; Betamethasone Valerate; Humans; Male; Ointments; Prurigo; Ultraviolet Therapy; Whole-Body Irradiation | 2011 |
A case of actinic prurigo in Thailand.
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Betamethasone Valerate; Cheilitis; Female; Glucocorticoids; Histamine H1 Antagonists; Humans; Photosensitivity Disorders; Prurigo; Thailand | 2000 |